ratio of recurring income to total revenue, (3) allowing REITs to seek circular resolutions (not including the resolution on sale of assets), (4) reducing the time required for delivering documents

49.34 17.69% Finance cost 49.11 68.10 18.99 38.67% Income tax expenses 48.04 57.52 9.48 19.73% Net profit 181.71 202.58 20.87 11.49% Net profit ratio (ROS) 17.16% 15.74% Earnings per share (Baht) 0.34

subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st

Baht in the year 2016, due to revenue increased. Finance cost increase 4.90 million Baht and income tax 2.19 million Baht. The company experience net profit at 8.17 million Baht or profit by 0.08 Baht

contract work 12.44 8.50% 7.14 6.12% -5.30 -42.57% Revenue from services income 1.20 0.82% 0.49 0.42% -0.71 -58.84% Revenue from rental income 0.58 0.39% 0.70 0.60% 0.12 21.63% Total revenues 146.29 100.00

the parent) of Baht 310 million and earnings per share of Baht 0.16 for the first quarter of 2019, an increase of 20 percent when compared to the consolidated profits (attributable to equity holders of

0.94% 576.65 8.97% (503.65) -87.34% Finance cost and tax income 1.61 0.02% (4.54) -0.07% 6.15 135.46% Net profit (22.13) -0.29% 423.62 6.59% (445.75) -105.22% Basic earnings per share (Baht per share

stated ) Q1 2017 Q1 2016 Change Amount % Total Revenues 3,946 3,910 36 0.9% Sales and service income 3,829 3,818 8 0.2% Other income 117 92 25 27.9% Cost of sales and services 3,533 3,550 (17) -0.5% SG&A

consolidated sales and services income excluding construction revenue under concession agreement of 3,075.80 million Baht, decreased by 186.46 million Baht or 5.72%) and Net profit attributable to Equity holders

Income - 160,996 19.63 - 480 0.07 - 160,516 33,440.83 Total Revenue 49,344 819,948 100.00 27,539 732,209 100.00 21,805 87,739 11.98 1. Revenue from Sales 1.1 Revenues from sales of biodiesel business to